19 August 2020 : Database Analysis
Screening and Identification of Potential Peripheral Blood Biomarkers for Alzheimer’s Disease Based on Bioinformatics Analysis
Xin Wang1BCD, Lantao Wang1AEF*DOI: 10.12659/MSM.924263
Med Sci Monit 2020; 26:e924263
Table 1 Summary of Alzheimer’s disease (AD) microarray datasets from different Gene Expression Omnibus (GEO) datasets.
| Series | Samples | Source | Platform | Affymetrix GeneChip | |
|---|---|---|---|---|---|
| 1 | GSE18309 | 3 MCI, 3 AD and 3 normal controls. | PBMCs | GPL570 | [HG-U133_Plus_2] Affymetrix Human Genome U133 Plus 2.0 Array |
| 2 | GSE97760 | 9 female advanced AD patients (age 79.3±12.3 years) and 10 age–matched female healthy controls (age 72.1±13.1 years) | PBMCs | GPL16699 | Agilent-039494 SurePrint G3 Human GE v2 8x60K Microarray 039381 (Feature Number version) |
| MCI – mild cognitive impairment; AD – Alzheimer’s disease; PBMCs – peripheral blood mononuclear cells. | |||||